​

Astrana Health (ASTH) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChartTranscripts

ASTH Stock Forecast

Astrana Health (ASTH) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $43.00, with a high of $50.00 and a low of $36.00. This represents a 37.03% increase from the last price of $31.38.

$30 $36 $42 $48 $54 $60 High: $50 Avg: $43 Low: $36 Last Closed Price: $31.38

ASTH Stock Rating

Astrana Health stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 0 6 Strong Sell Sell Hold Buy Strong Buy

ASTH Price Target Upside V Benchmarks

TypeNameUpside
StockAstrana Health37.03%
SectorHealthcare Stocks 35.25%
IndustryMedical Care Facilities Stocks23.83%

Price Target Trends

1M3M12M
# Anlaysts125
Avg Price Target$36.00$43.00$54.20
Last Closing Price$31.38$31.38$31.38
Upside/Downside14.72%37.03%72.72%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25-103--13
Mar, 25-102--12
Feb, 25-102--12
Jan, 25-102--12
Dec, 24-102--12
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 01, 2025Barclays$36.00$29.8620.56%14.72%
Mar 03, 2025Robert W. Baird$50.00$26.4888.82%59.34%
Oct 03, 2024David LarsenBTIG$70.00$57.8720.96%123.07%
Aug 15, 2024Michael HaRobert W. Baird$67.00$46.5843.84%113.51%
Jun 27, 2024Chris O'CullStifel Nicolaus$48.00$40.5018.52%52.96%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 14, 2024Cowen & Co.Buyinitialise
Oct 10, 2024KeyBancSector Weightinitialise
Oct 03, 2024BTIGBuyBuyhold
Jul 11, 2024GuggenheimNeutralNeutralhold

Financial Forecast

EPS Forecast

$-1 $0 $1 $2 $3 $4 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.65$1.57$1.00$1.30$0.90----
Avg Forecast$0.92$1.59$1.05$1.18$1.14$1.44$1.98$2.40$2.99
High Forecast$1.01$1.74$1.18$1.32$1.22$1.68$2.27$2.68$3.34
Low Forecast$0.87$1.50$0.94$1.04$1.07$1.20$1.56$2.11$2.63
Surprise %-170.65%-1.26%-4.76%10.17%-21.05%----

Revenue Forecast

$0 $900M $2B $3B $4B $5B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$370.25M$773.91M$1.14B$1.39B$2.03B----
Avg Forecast$674.90M$755.06M$1.10B$1.37B$1.97B$2.57B$3.04B$3.32B$3.71B
High Forecast$724.73M$810.80M$1.21B$1.38B$2.01B$2.67B$3.10B$3.62B$4.04B
Low Forecast$645.35M$722.00M$1.01B$1.37B$1.95B$2.40B$2.97B$3.01B$3.37B
Surprise %-45.14%2.50%4.27%0.86%3.27%----

Net Income Forecast

$-50M $0 $50M $100M $150M $200M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-23.75M$68.92M$45.17M$60.72M$43.15M----
Avg Forecast$43.19M$74.64M$49.19M$60.72M$53.91M$70.29M$94.48M$120.50M$140.73M
High Forecast$47.33M$81.80M$55.71M$62.07M$57.63M$79.20M$106.62M$126.22M$157.25M
Low Forecast$40.73M$70.39M$44.17M$48.91M$50.20M$56.64M$73.63M$99.47M$123.92M
Surprise %-155.00%-7.66%-8.16%--19.97%----

ASTH Forecast FAQ

Is Astrana Health stock a buy?

Astrana Health stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Astrana Health is a favorable investment for most analysts.

What is Astrana Health's price target?

Astrana Health's price target, set by 6 Wall Street analysts, averages $43 over the next 12 months. The price target range spans from $36 at the low end to $50 at the high end, suggesting a potential 37.03% change from the previous closing price of $31.38.

How does Astrana Health stock forecast compare to its benchmarks?

Astrana Health's stock forecast shows a 37.03% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the medical care facilities stocks industry (23.83%).

What is the breakdown of analyst ratings for Astrana Health over the past three months?

  • April 2025: 0% Strong Buy, 76.92% Buy, 23.08% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 0% Strong Buy, 83.33% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 0% Strong Buy, 83.33% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.

What is Astrana Health’s EPS forecast?

Astrana Health's average annual EPS forecast for its fiscal year ending in December 2025 is $1.44, marking a 60.00% increase from the reported $0.9 in 2024. Estimates for the following years are $1.98 in 2026, $2.4 in 2027, and $2.99 in 2028.

What is Astrana Health’s revenue forecast?

Astrana Health's average annual revenue forecast for its fiscal year ending in December 2025 is $2.57B, reflecting a 26.54% increase from the reported $2.03B in 2024. The forecast for 2026 is $3.04B, followed by $3.32B for 2027, and $3.71B for 2028.

What is Astrana Health’s net income forecast?

Astrana Health's net income forecast for the fiscal year ending in December 2025 stands at $70.29M, representing an 62.91% increase from the reported $43.15M in 2024. Projections indicate $94.48M in 2026, $120.5M in 2027, and $140.73M in 2028.